Vascular complications of diabetes in Lebanon: Experience at the American University of Beirut

Abstract

Aim To examine the metabolic control and presence of

complications, among a cohort of diabetic patients in Lebanon. Method A total of 313 diabetic patients presenting for their usual care were screened in a cross-sectional manner for metabolic control and presence of complications at the American University of Beirut.

Results Only 235 subjects completed their data of whom 220 (93%) had type 2 diabetes with mean duration of disease of 8.2 (±6.6) years. Only 30% had haemoglobin A_1C < 7%, and 35.5% had low-density lipoprotein Cholesterol < 2.6 mmol/L. About 50.5% were obese, 34.9% current smokers, and 40.7% had blood pressure ≥ 140/90 mmHg. Microvascular complications were present as 46.3, 39.9 and 33% for albuminuria, neuropathy, 33% for albuminuria, neuropathy, and retinopathy, respectively. Macrovascular complications were as follows: 19.3, 18.3 and 4.1% for coronary artery disease, peripheral vascular disease and cerebrovascular disease, respectively.

Conclusions This study highlights the poor control and high prevalence of vascular complications among adult type 2 diabetic patients in Lebanon.

Keywords

diabetic complications epidemiology Lebanon type 2 diabetes.

Get full access to this article

View all access options for this article.

References

Hossain P. , Kawar B. , El Nahas M. Obesity and diabetes in the develop

ing world a growing challenge. N Engl J Med 2007;356:213-16.

Hirbli K. , Jambeine M. , Slim H. et al. Prevalence of diabetes in greater Beirut. Diabetes Care 2005;28:1262.

WHO 2008, Prevalence of diabetes in the WHO Eastern Mediterranean Region. Available from: http://www.who.int/diabetes/facts/world_figures/en/index2.html

ADA. Standards of medical care in diabetes. Diabetes Care 2007;30:S4-S41

Akel M. , Hamadeh G. Quality of diabetes care in university health center in Lebanon. Int J Qual Health Care 1999;11:517-21.

Major S. , Salti I. , Masri A. et al. Managing diabetes mellitus in a Lebanese Primary Care Center . Working towards change. Leb Med J 1998;46:182-7

Salti I. , Khogali M. , Alam S. et al. Epidemiology of diabetes in relation to other cardiovascular risk factors in Lebanon. East Mediterr Health J 1997;3:462-71.

Unnikrishnan R. , Rema M. , Pradeepa R. et al. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Epidemiology study. Diabetes Care 2007;30:2019-24.

10.

Girach A. , Manner D. , Porta M. Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract 2006;11:1471-83.

11.

Al-Maskari F. , El- Sadig M. Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC Ophthalmol 2007;7:11.

12.

Rema M. , Premkumar S. , Anitha B. et al. Prevalence of diabetic retinopathy in urban India: the chennai urban rural epidemiology study (CURES). Invest Ophthalmol Vis Sci 2005;46:2328-33.

13.

Fleming B. , Greenfield S. , Engelgau M. et al. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 2001;24:1815-20.

14.

Saaddine J. , Cadwell B. , Gregg E. et al. Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988-2002 . Ann Intern Med 2006;144:465-74.

15.

Aace. DM Clinical Practice Guidelines Task Force: American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus. Endocr Pract 2007;13:40-7.